Skip to main content

Pay Bill Portals

Our Tests
Our Services
- - Oncology
    - - SERVICES
        
        NateraCore Services
        
        Pharma Partnership
        
        Real-World Data
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
        
        Contact Us
    - - FOR CLINICIANS
        
        Schedule Session With Client Services
        
        Oncology Portal
        
        Order a Test Kit
        
        Contact Us
  - Organ Health
    - - SERVICES
        
        NateraCore Services
        
        ProReach
        
        EMR Integration
        
        Pharma Services
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Order a Renasight Kit
        
        Contact Us
        
        Pricing and Billing Information
    - - FOR CLINCIANS
        
        Organ Health Portal
        
        Order a Renasight Kit
        
        Contact Us
  - Women’s Health
    - - SERVICES
        
        NateraCore Services
        
        Constellation
        
        EMR Integration
    - - FOR PATIENTS
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
        
        Women’s Health Portal
        
        Contact Us
    - - FOR CLINICIANS
        
        Order Tests and Track Status on NateraConnect
        
        View Patient Results on NateraConnect
        
        Contact Us
Patient Resources
- - Oncology
    - - LEARN
        
        Signatera
        
        Altera
        
        Empower
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule Session with Patient Coordinator
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Organ Health
    - - LEARN
        
        Prospera
        
        Renasight
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule Blood Draw (Existing Patients)
        
        Schedule a Genetic Information Session
        
        Pricing and Billing Information
    - - CONNECT
        
        Contact Us
  - Women’s Health
    - - LEARN
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Spectrum
        
        View All Patient Resources
    - - EXISTING PATIENTS
        
        Schedule a Genetic Information Session
        
        Schedule Blood Draw (Existing Patients – USA)
        
        Schedule Blood Draw (Existing Patients – Canada)
        
        Pricing and Billing Information
        
        Women’s Health Portal
    - - CONNECT
        
        Contact Us
Clinical Resources
- - Oncology
    - - CLINICAL RESOURCES
        
        Signatera
        
        Signatera Publications
        
        Altera
        
        Empower
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        Signatera Research Pipeline
        
        Natera Sponsored Trials
    - - CONNECT
        
        Oncology Portal
        
        Contact Us
  - Organ Health
    - - CLINICAL RESOURCES
        
        Organ Health Publications
        
        Prospera
        
        Renasight
        
        View All Clinician Resources
    - - RESEARCH STUDIES
        
        ProActive Study
        
        PEDAL Study
        
        Trifecta Study
        
        MOTR Study
    - - CONNECT
        
        Organ Health Portal
        
        Contact Us
  - Women’s Health
    - - CLINICAL RESOURCES
        
        Women’s Health Publications
        
        Horizon
        
        Panorama
        
        Empower
        
        Vistara
        
        Anora
        
        Spectrum
        
        Natera Academy Provider Education Hub
        
        View All Clinician Resources
    - - RESEARCH STUDIES
    - - CONNECT
        
        Contact Us
Company
Search for:
Pay Bill

Portals
Search for:

Natera, Inc.

- Altera
- Anora
- Empower
- Horizon
- Panorama
- Prospera
- Renasight
- Signatera
- Spectrum
- Vistara
- Blog
- Videos
- Brochure
- Whitepaper
- Manual
- Poster
- Report
- Study
- Webinars
- Natera Academy

Recent Searches

Home
Signatera Webinars
Target, Track, Treat: Optimizing GI Cancer Management with Molecular Residual Disease Testing

Target, Track, Treat: Optimizing GI Cancer Management with Molecular Residual Disease Testing

Published Date September 17, 2025

No Previous Videos
Next Video

New data from ASCO 2025 & clinical performance of Natera’s ultra-sensitive MRD platform

Related Content

New data from ASCO 2025 & clinical performance of Natera’s ultra-sensitive MRD platform

Watch Video
ctDNA monitoring with Signatera: An overview for transplant providers

Watch Video
Tiny Traces, Big Impact: Changing the Paradigm in Breast Cancer Management with MRD Testing

Watch Video
4 months ago
Optimizing Patient Care in MIBC with MRD Testing, Real-world Clinical Cases

Watch Video
5 months ago
New Data Review Can treating molecular residual disease (MRD) in colorectal cancer improve outcomes

Watch Video
7 months ago
MRD Testing in NSCLC to Personalize Patient Care

Watch Video
7 months ago
Unlocking new uses for old drugs

a revolution in precision oncology using evidence-based MRD testing

Watch Video
7 months ago
New data: Optimizing breast cancer care and drug development with molecular residual disease testing

Watch Video
10 months ago
The Tipping Point: How clinically validated MRD testing is transforming patient management in colorectal cancer

Watch Video
10 months ago
Post ESMO review - How molecular residual disease testing is transforming cancer care

Watch Video
about 1 year ago
ASCO24 Summary: Latest data on ctDNA as a patient selection and early efficacy marker in drug development

Watch Video
over 1 year ago
Latest data on ctDNA as a patient selection and early efficacy marker for gynecologic cancers

Watch Video
over 1 year ago
How ctDNA can transform interventional trial design for GI cancers

Watch Video
over 1 year ago
Seeing the Forest Through the Trees: How tumor informed MRD testing can illuminate the treatment pathway in GI cancer

Review recently presented MRD data in colorectal and pancreatic cancer, exploring the potential impact on patient care

Watch Video
almost 2 years ago
Webinar: Breast Cancer 2023 Data & Post-SABCS Summary

ctDNA in drug development for breast cancer Multiple studies have demonstrated that detection of molecular residual disease (MRD) is associated with poor prognosis in breast cancer. Ongoing prospectiv

Watch Video
almost 2 years ago
Panel Discussion: How ctDNA Testing is Informing the Management of Patients With GI Cancer - Direct

Our experts will review real-world case studies showing when and where ctDNA can help inform shared decision-making.

Watch Video
almost 2 years ago
Locate and Track: ctDNA Monitoring in NSCLC with Signatera

Learn about the clinical applications for Signatera in NSCLC across early stage and metastatic disease

Watch Video
almost 2 years ago
ctDNA monitoring to optimize immunotherapy treatment decisions

Dive into the latest data highlighting ctDNA for immunotherapy treatment response monitoring

Watch Video
about 2 years ago
Detect. Monitor. Optimize: Signatera’s Impact on Breast Cancer Management

Learn more about the latest Signatera™ data in high-risk breast cancer: Newly published data from the I-SPY 2 trial reinforcing the utility of ctDNA monitoring during neoadjuvant therapy Updates from

Watch Video
about 2 years ago
Post-ASCO Summary: ctDNA as a patient selection and early efficacy marker in drug development

Our expert speakers will discuss the latest data from ASCO 2023 and other recent publications and congresses. This will be followed by a panel discussion on the future directions and implications for

Watch Video

Return to Resource Library

© Natera, Inc.

Our Tests
Our Services
Patient Resources
Clinical Resources
- Resource Library
- Provider Portals
Company
Contact

Natera Licenses
IT Security Compliance
Natera Notice of Data Collection for California Residents
HIPAA Notice of Privacy Practices
Privacy Policy
Terms of Use
Sitemap

The tests described have been developed and their performance characteristics determined by the CLIA-certified laboratory performing the test. The tests have not been cleared or approved by the US Food and Drug Administration (FDA). CAP accredited, ISO 13485 certified, and CLIA certified. © 2024 Natera, Inc. All Rights Reserved.